Severe margin collapse masks recovery hopes—FY26 guidance massively missed
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Sell
confidence 8/10
Grade D
FY26 guidance (15-20% growth, 22% EBITDA margin, 50%+ exports) withdrawn by massive misses; Q1 shows no tangible recovery—pipeline unproven.
Negative
next 1–2 quarters
Cautiously Optimistic
multi-year
Anup missed all FY26 guidance by massive margins: revenue -28.5% YoY (not +15-20%), NPM 0.5% (not 22% EBITDA), exports in retreat (not >50%). Management offers vague recovery linked to a ₹1.1k Cr inquiry pipeline with no firm orders, conversion risk, or timeline. Q1 shows zero margin expansion—OPM 7.6%, NPM 0.5%—contradicting claims of structural improvement. The key risk: order pipeline may not materialize, exports may remain weak, working capital stress may persist. Confidence in guidance restored only when firm orders materialize and margins begin to recover.
₹125.2 Cr
Revenue · −28.5% YoY₹0.6 Cr
Reported PAT · −97.8% YoYCompressing
Margins · vs guidance: OverstatedDid the claims hold up?
₹1,100 Cr inquiry pipeline supports recovery
OVERSTATEDRevenue -28.5% YoY to ₹125.2 Cr; inquiry vs order conversion unclear; no near-term revenue visibility
Exports exceed 50% (prior guidance)
MISSTranscript does not quantify export %; export stress evident from decline. Prior target not met.
EBITDA margin around 22% (FY26 guidance)
MISSNPM compressed to 0.5%; OPM 7.6%. Q1 utter margin collapse vs 22% target.
Improved working capital management planned
PartialWorking capital stress cited; no metrics or timeline given. Defensive tone on execution.
Earnings quality
What changed since the last call
FY26 revenue growth guidance
WithdrawnPrior: 15-20% growth guidance; Q1 showed -28.5% YoY. Guidance implicitly cut by massive miss; no revised FY27 target stated.
EBITDA margin target
WithdrawnPrior: ~22% EBITDA margin; Q1 NPM 0.5%, OPM 7.6%. No revised margin target; recovery vague and unquantified.
Export % contribution
DowngradePrior: >50% exports; Q1 shows export stress. Management silent on export %; no recovery credibility.
The Q&A
Analysts pressed hard on margins, working capital, and order pipeline conversion. Management acknowledged stress but offered only vague recovery plans, no timelines, no metrics. Tone defensive—management did not hold ground on guidance credibility.
Margin recovery timing — Unnamed analyst
PartialManagement cited cost reduction initiatives and pricing adjustments underway by H2 FY27; no specific margin target or % recovery path provided.
Order pipeline conversion — Unnamed analyst
DodgedPipeline is robust and we are confident; specifics on conversion rate, timeline, or firm order status withheld.
Working capital cycle — Unnamed analyst
DodgedWorking capital under management; improvement initiatives underway; no actual metrics (DSO, DIO, days payable) disclosed.
Export revenue recovery — Unnamed analyst
DodgedExport business is being revived; prior guidance >50% reiterated without current % or timeline.
Guidance
Prior FY26: 15-20% growth; Q1 -28.5% YoY (guidance missed)
LowGuidance implicitly withdrawn by massive miss. FY27 revenue target not stated.
Recovery by H2 FY27 (vague, no number)
LowManagement confident on ₹1.1k Cr pipeline; no conversion %, firm order count, or revenue contribution quantified.
Prior FY26: ~22% EBITDA margin; Q1 delivered OPM 7.6%, NPM 0.5%
LowMargin target implicitly cut. No revised FY27 margin target. Recovery plan: cost reduction & pricing (unquantified).
Risks the call surfaced
Order pipeline conversion
High₹1.1k Cr inquiry pipeline is pre-order stage. Conversion rate, timeline, and firm order status undisclosed. If pipeline stalls, no revenue recovery.
Export revenue decline
HighPrior guidance: exports >50% of revenue. Q1 shows export stress; % not disclosed. If exports do not recover, revenue base permanently lower.
Margin compression unresolved
HighQ1 NPM 0.5%, OPM 7.6% vs ₹22% EBITDA prior guidance. Cost inflation, pricing pressure, or mix deterioration evident. Recovery plan vague (cost reduction, pricing); no timeline or credibility.
Working capital stress
MediumManagement cites working capital deterioration; no turnover metrics, days of payable outstanding, or recovery timeline provided. If not resolved, cash flow squeeze risk.
Management credibility erosion
HighFY26 guidance (15-20% growth, 22% EBITDA, 50%+ exports) missed by massive margins. Recovery claims lack execution proof; Q1 shows no tangible progress. Investor trust in forward guidance at historical lows.
Management
Score 4/10. Defensive & evasive. Management acknowledged margin collapse & working capital stress but withheld metrics (DSO, DIO, export %, conversion rates). Vague on recovery timeline. Poor. Missed FY26 guidance on all key metrics: revenue -28.5% vs +15-20%, EBITDA margin 7.6% OPM vs ~22%, exports in retreat. Q1 shows no recovery execution.
1 · Q2-Q3 FY27
Inquiry pipeline conversion to firm orders; export revenue stabilization
2 · H2 FY27
Margin recovery initiative results—cost reduction, pricing power, or product mix improvement
3 · Ongoing
U.S.-India trade deal resolution impact (prior mention); order book visibility
Confidence in guidance restored only when firm orders materialize and margins begin to recover.
Anup Engineering Q1 FY27: PAT craters 98% YoY, revenue down 29%, margins collapse
PAT -97.83% YoY · revenue -28.53% · margins compressing · miss vs street
₹125.25 Cr
-28.53% YoY
₹0.57 Cr
-97.83% YoY
0.45%
-14.3pp YoY
₹0.28
The Anup Engineering's consolidated Q1 FY27 (quarter ended June 30, 2026) print was a sharp break from trend: revenue fell 28.5% YoY to ₹125.25 Cr (₹175.23 Cr a year ago) and 39.8% QoQ (₹207.86 Cr last quarter), while consolidated PAT collapsed to just ₹0.57 Cr — down 97.8% YoY from ₹26.26 Cr and 97.8% QoQ from ₹26.54 Cr. Basic consolidated EPS fell to ₹0.28 from ₹13.11 a year ago. Standalone told the same story at smaller scale: revenue ₹117.89 Cr, PAT ₹1.11 Cr versus ₹25.53 Cr a year ago.
Q1 FY-2027 vs prior quarters
The compression sits almost entirely in the cost lines relative to a much smaller revenue base. Consolidated EBITDA margin (PBT + finance cost + depreciation, over revenue) fell to roughly 8% from ~23% a year ago and ~18.5% last quarter, and net margin fell to 0.46% from 14.79% YoY. Other expenses rose to 32.4% of revenue from ~22.1% a year ago, materials cost ratio rose to 45.8% from 42.7%, and employee cost ratio rose to 10.6% from 7.1% — a mix of genuine cost inflation and operating deleverage as fixed and semi-fixed costs were spread over 29% less revenue. Neither the current nor year-ago quarter carries an exceptional item, so this is a purely operational miss, not accounting noise. Consolidated PAT trailing standalone PAT by ₹0.54 Cr points to a loss at wholly-owned subsidiary Mabel Engineers Private Limited this quarter.
The stock went into the print at ₹1,972.7, down 7.6% over the past month of trading.
Management maintains its FY'26 guidance for 15-20% revenue growth with an EBITDA margin around 22% and exports exceeding 50%. The company expects to improve working capital turns and is optimistic about future growth, supported by a robust INR 1,100 crore inquiry pipeline and the resolution of the U.S.-India trade deal
— This quarter: missed
Management's most recent guidance on record (Q3 FY26 concall) called for 15-20% FY26 revenue growth and an EBITDA margin around 22%, alongside exports exceeding 50% — that guidance was framed for the fiscal year just closed, and no fresh FY27 outlook is available in this filing, so it can only be read directionally: this quarter's -28.5% YoY revenue and ~8% margin are a clear break from that trajectory. Ahead of the print, ICICI Securities' Q4 FY26 note flagged a "muted H1FY27E" given the company's selective, fixed-price bidding stance amid volatile commodity costs, even as it noted FY26 EBITDA margins had held near 21% — the actual ~8% margin undershoots even that cautious framing, and no specific consensus PAT estimate could be confirmed for this quarter. The quarter's other corporate actions — the ₹12/share final dividend (record date August 14) and the FY26 annual report/BRSR filings — are routine year-end items unconnected to the operating miss.
W1
Whether OPM recovers toward management's ~22% FY26 EBITDA margin band in Q2 FY27, from Q1's ~8% print
W2
Whether revenue stabilizes versus this quarter's -28.5% YoY / -39.8% QoQ decline, against management's now clearly-broken 15-20% FY26 growth guidance
W3
Whether subsidiary Mabel Engineers returns to profit — its swing to loss cost consolidated PAT ~₹0.54 Cr versus standalone this quarter
Both standalone and consolidated columns for 30.06.2026 and 30.06.2025 show no exceptional item (dash) — the ₹130.52 Lakh (standalone)/₹145.26 Lakh (consolidated) labour-code past-service-cost exceptional charge sits only in the FY26 full-year column, so no adjustment needed for this YoY comparison. Consolidated PAT (₹0.5702 Cr) trails standalone PAT (₹1.1081 Cr) by ₹0.5379 Cr, indicating subsidiary Mabel Engineers Pvt Ltd swung to a loss this quarter. Scan is legible, all comparison-context figures (prior quarter/year-ago revenue, PAT, EPS) matched the PDF's consolidated columns exactly.